Hovid Sdn Bhd in Consumer Health (Malaysia)

July 2013 | 2 pages | ID: H4C7EEBDAE9EN
Euromonitor International Ltd

Abstracts

Over the forecast period, Hovid Sdn Bhd is expected to focus on strengthening its competitiveness in the prescription drugs category. As the player has always undertaken a follower strategy as opposed to innovator over the review period, the activity levels in terms of new product innovations within consumer health will likely remain low in the future.

Euromonitor International Local Company Profiles are a concise set of briefings detailing the strategic direction taken by a company. Discover key contact details, the company background and their competitive positioning through this collection of snapshot company profiles.

Product coverage: Allergy Care, Herbal/Traditional Products, OTC, Paediatric Consumer Health, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the Consumer Health market;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market’s major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Contents

Strategic Direction
Key Facts
Summary 1 Hovid Sdn Bhd: Key Facts
Company Background
Production
Competitive Positioning
Summary 2 Hovid Sdn Bhd: Competitive Position 2012